Passage Bio Financial Overview
Passage Bio's market cap is currently $28.11M. The company's EPS TTM is $-2.44; its P/E ratio is -0.65; Passage Bio is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-2.57. See an overview of income statement, balance sheet, and cash flow financials.
